Category: VascularSyndicate content

Vascular

Report: J&J puts Cordis on the block

August 29, 2014 by Arezu Sarvestani

Johnson & Johnson puts its Cordis vascular device business on the auction block after years of sluggish growth.

Report: J&J's selling its Cordis division

Healthcare giant Johnson & Johnson (NYSE:JNJ) is looking to divest its Cordis business after years of lackluster sales for the company's stents, catheters and other vascular devices, according to a report from the Wall Street Journal.

Sequent launches U.S. clinical trial of brain aneurysm device

August 29, 2014 by Arezu Sarvestani

California's Sequent Medical begins enrolling patients in an IDE clinical trial of its Web aneurysm embolization system.

Sequent launches U.S. clinical trial of brain aneurysm device

Medtech company Sequent Medical enrolled the 1st 4 patients in a new U.S. clinical trial aimed at winning FDA approval for its Web aneurysm protection implant.

The Web implant is made of a Nitinol mesh that is delivered in a "stent-like" manner and deployed into the pouch formed by an aneurysm in order to prevent blood from flowing in. The device already has approve in the European Union.

Theragenics to hire 50 in Costa Rica after cutting 139 in Texas

August 28, 2014 by Arezu Sarvestani

Georgia-based Theragenics has about 50 new positions to fill as it prepares to begin manufacturing in Costa Rica. The company cut nearly 140 workers from its Texas-based Galt Medical operations earlier this year.

Theragenics to hire 50 new workers for Costa Rica facility

Surgical devices maker Theragenics is looking to add some employees overseas at it prepares to ramp up manufacturing at a new facility in Costa Rica, part of larger outsourcing plans that included cuts in the U.S.

Covidien's atherectomy study finally hits JACC

August 20, 2014 by Arezu Sarvestani

Final results from Covidien's DEFINITIVE LE study, originally closed in 2012, finally appear in the Journal of American College of Cardiology, Cardiovascular Interventions.

Covidien's atherectomy study hits JAMA

It may have taken 2 years but final results from Covidien's (NYSE:COV) DEFINITIVE LE study finally appeared in the Journal of the American College of Cardiology's Cardiovascular Interventions issue.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cook Medical recalls retrieval device over embolization concerns

August 19, 2014 by Arezu Sarvestani

Indiana-based Cook recalls its CloverSnare vascular retrieval snares after at least 6 complaints that the devices came apart during use.

Cook Medical recalls retrieval device over embolization concerns

Cook Medical announced this week that it recalled nearly 700 units of its CloverSnare 4-Loop Vascular Retrieval Snare devices after receiving complaints that the devices came apart during use.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Transluminal Tech lands E.U. win for bioabsorbable vascular closure

August 4, 2014 by Arezu Sarvestani

New York-based Transluminal Technologies touts its 1st CE Mark for the 1st-of-its-kind Velox CD vascular closure system.

Transluminal Tech lands E.U. win for bioabsorbable vascular closure

Transluminal Technologies is ready to take on the European market with CE Mark approval for its flagship Velox CD vascular closure devices.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp